Takeda Pharmaceutical (TKPHF) Shares Outstanding (Diluted Average) (2017 - 2026)

Takeda Pharmaceutical's Shares Outstanding (Diluted Average) history runs 10 years deep, the most recent figure standing at $0.76 for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 73.12% year-over-year to $0.76; the TTM figure through Mar 2026 stood at $0.76 (up 73.12% YoY), while the FY2026 annual figure was $0.79, up 80.08% from the prior year.
• Shares Outstanding (Diluted Average) was $0.76 for Q1 2026 at Takeda Pharmaceutical, down from $0.88 in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.53 in Q1 2023 to a low of $0.18 in Q3 2023.
• Historically, Shares Outstanding (Diluted Average) has averaged $0.73 across 5 years, with a median of $0.63 in 2023.
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Diluted Average) slumped 76.48% in 2023, then surged 331.28% in 2024.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $1.29 in 2022, then slumped by 51.25% to $0.63 in 2023, then surged by 37.43% to $0.87 in 2024, then advanced by 1.37% to $0.88 in 2025, then retreated by 13.12% to $0.76 in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $0.76 (Q1 2026), $0.88 (Q4 2025), and $0.48 (Q3 2025), per Business Quant data.